[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myofacial-pain-syndromes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myofacial-pain-syndromes":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,56],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100637000","evaluation-of-the-effect-of-adding-sodium-bicarbonate-to-lidocaine-in-the-treatment-of-myofascial-pain-syndrome-100637000",false,"NCT07572994","Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome","Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome Using Surface Electromyography (sEMG)","BIC-LIDO-MPS","Inclusion Criteria:\n\nPatients aged 16 to 70 years Clinical diagnosis of myofascial pain syndrome (MPS) Presence of active myofascial trigger points Pain duration ≥ 3 months Pain intensity ≥ 4 on the Visual Analog Scale (VAS) Trigger points located in accessible muscles No trigger point injection in the affected area within the past 3 months Ability and willingness to provide informed consent Willingness to comply with study procedures and follow-up visits\n\nExclusion Criteria:\n\nKnown allergy or hypersensitivity to lidocaine, sodium bicarbonate, or other amide-type local anesthetics Current use of anticoagulants or presence of bleeding disorders Local or systemic infection at or near the injection site History of fibromyalgia, cancer-related pain, or central pain syndromes Major psychiatric disorders (e.g., schizophrenia, severe depression) Recent trauma or surgery to the neck, shoulder, or back within the past 6 months Use of analgesics (e.g., NSAIDs, opioids) within 5 days prior to injection Severe systemic diseases (e.g., uncontrolled diabetes, liver failure, kidney failure, severe cardiovascular disease)\n\n\\-","ALL","16 Years","70 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study is designed to evaluate a method to improve the treatment of myofascial pain syndrome (MPS), a common condition that causes muscle pain, tenderness, and reduced movement due to the presence of trigger points in muscles.\n\nA commonly used treatment for this condition is the injection of a local anesthetic called lidocaine into these trigger points to relieve pain. However, the pain relief from lidocaine alone may be temporary.\n\nIn this study, we are investigating whether adding a small amount of sodium bicarbonate to lidocaine can improve its effectiveness. Sodium bicarbonate may reduce the pain during injection and help the anesthetic work faster and possibly last longer.\n\nParticipants in this study will be randomly assigned into one of two groups:\n\nOne group will receive lidocaine alone. The other group will receive lidocaine mixed with sodium bicarbonate.\n\nThe injection will be performed once into the painful muscle trigger points under sterile conditions.\n\nPain levels will be assessed using a simple pain scale, and muscle activity will be measured using a non-invasive technique called surface electromyography (sEMG), which records muscle electrical activity. These measurements will be taken before the injection, immediately after, and during follow-up visits.\n\nParticipants may experience mild discomfort during or after the injection, but all procedures are routinely used in clinical practice. Safety measures will be in place to manage any possible side effects.\n\nThe goal of this study is to determine whether the combined injection provides better pain relief, improves muscle function, and enhances patient comfort compared to lidocaine alone.",[28,29,30,31,32],"Myofacial Pain","Myofacial Pain Syndrome","Myofacial Pain Syndromes","Trigger Point Pain, Myofascial","Myofascial Pain Dysfunction Syndrome",[34,35,36,37,38,39,40,41,42,43],"lidocaine","Sodium Bicarbonate","Buffered Lidocaine","Trigger Point Injection","Surface Electromyography","Myofascial Trigger Points","Muscle Pain","Injection Pain","Muscle Activity","Musculoskeletal Pain","NOT_YET_RECRUITING","2026-05-01",{"date":47,"type":48},"2026-05-07","ACTUAL",{"date":45,"type":22},{"date":51,"type":22},"2026-10-01",{"name":53,"class":54},"Cairo University","OTHER",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":4,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":4,"studyType":23,"phases":67,"briefSummary":68,"conditions":69,"keywords":4,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":55},"100585232","kt-vs-iastm-on-upper-trapezius-myofascial-trigger-points-to-compare-effect-of-kt-vs-iastm-on-pain-intensity-pain-pressure-threshold-cervical-range-of-motion-and-functional-disability-level-100585232","NCT06899685","KT vs IASTM on Upper Trapezius Myofascial Trigger Points To Compare Effect of KT VS IASTM on Pain Intensity, Pain Pressure Threshold, Cervical Range of Motion and Functional Disability Level.","KINESIOTAPING VERSUS INSTRUMENT ASSISTED SOFT TISSUE MOBILIZATION ON UPPER TRAPEZIUS MYOFASCIAL TRIGGER POINTS: A RANDOMIZED CONTROLLED TRIAL Kinesiotaping (KT) is a Non-invasive Method to Treat Musculoskeletal Disorders. it is Non-invasive, Painless, and Less Time-consuming Than Other Options With Fewer Side Effects. IASTM is a Traditional Chinese Therapy Known as \"Guasha\". IASTM is a Simple and Practical Technique","Inclusion Criteria:\n\n\\- 1) Fifty subjects with age ranged from 18 to 23 years old (Formen et al., 2014).\n\n2\\) From both genders with normal BMI ranges between 18.5:24.9 kg\u002Fm2. Had MTrPs of unilateral UT muscle (Shamseldeen et al., 2023).\n\nExclusion Criteria:\n\n* 1\\. History of whiplash injury (Emshi et al., 2021). 2. History of head, neck, cervical spine or shoulder surgery (Emshi., et al 2021) 3. History of cervical radiculopathy (Emshi et al., 2021) 4. Patients with malignancy (Shamseldeen et al., 2023). 5. Cervical spine fractures (Shamseldeen et al., 2023). 6. Myelopathy (Shamseldeen et al., 2023). 7. Having undergone physical therapy within the past three months before the study.\n\n  8\\. Non - rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection.\n\n  9\\. Rheumatologic condition as poly-articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases.\n\n  10\\. Presence of skin diseases (Luz Júnior et al., 2015). 11. Pregnancy (Luz Júnior et al., 2015).","19 Years","23 Years",{"count":66,"type":22},50,[25],"This study would answer the following question: Is there a difference in the effects between IASTM and KT on pain intensity level, pain pressure threshold, cervical range of motion (ROM), functional disability level and satisfaction level in subjects with upper trapezius myofascial trigger points?\n\nThe aims of this study are:\n\n1. To investigate the effect of KT and IASTM on pain intensity level in subjects with upper trapezius myofascial trigger points.\n2. To investigate the effects of KT and IASTM on pain pressure threshold in subjects with upper trapezius myofascial trigger points.\n3. To investigate the effects of KT and IASTM on cervical range of motion (ROM) in subjects with myofascial trigger points.\n4. To investigate the effect of KT and IASTM on functional disability level in subjects with upper trapezius myofascial trigger points.\n5. To investigate the effects of KT and IASTM on satisfaction level in subjects with myofascial trigger points.",[30],"RECRUITING","2025-03-26",{"date":73,"type":48},"2025-03-28",{"date":75,"type":48},"2024-08-01",{"date":77,"type":22},"2025-04-01",{"name":79,"class":54},"Reham Sayed Mesaed"]